DH Yoo
YOU?
Author Swipe
View article: SAT0146 Randomised double-blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results
SAT0146 Randomised double-blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results Open
View article: FRI0178 Rituximab is effective in the treatment of rheumatoid arthritis regardless of body mass index
FRI0178 Rituximab is effective in the treatment of rheumatoid arthritis regardless of body mass index Open
View article: AB0040 Immune modulatory effects of mesenchymal stem cell to mononuclear cells from patients with active adult onset still's disease
AB0040 Immune modulatory effects of mesenchymal stem cell to mononuclear cells from patients with active adult onset still's disease Open